Kathryn Moses

Kathryn Moses is currently the Director of Cell and Gene Therapy Strategy at The Dedham Group. Prior to that, Kathryn held various positions at different companies such as General Electric and Dow Coating Materials. Kathryn has a Bachelor of Science in Chemical Engineering from the University of Michigan and a Minor in Business Administration from the Stephen M. Ross School of Business.